Literature DB >> 11308292

Raft membrane domains: from a liquid-ordered membrane phase to a site of pathogen attack.

F G van der Goot1, T Harder.   

Abstract

While the existence of cholesterol/sphingolipid (raft) membrane domains in the plasma membrane is now supported by strong experimental evidence, the structure of these domains, their size, their dynamics, and their molecular composition remain to be understood. Raft domains are thought to represent a specific physical state of lipid bilayers, the liquid-ordered phase. Recent observations suggest that in the mammalian plasma membrane small raft domains in ordered lipid phases are in a dynamic equilibrium with a less ordered membrane environment. Rafts may be enlarged and/or stabilized by protein-mediated cross-linking of raft-associated components. These changes of plasma membrane structure are perceived by the cells as signals, most likely an important element of immunoreceptor signalling. Pathogens abuse raft domains on the host cell plasma membrane as concentration devices, as signalling platforms and/or entry sites into the cell. Elucidation of these interactions requires a detailed understanding raft structure and dynamics. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11308292     DOI: 10.1006/smim.2000.0300

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  71 in total

1.  Segregation of leading-edge and uropod components into specific lipid rafts during T cell polarization.

Authors:  C Gómez-Móuton; J L Abad; E Mira; R A Lacalle; E Gallardo; S Jiménez-Baranda; I Illa; A Bernad; S Mañes; C Martínez-A
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

2.  Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.

Authors:  Florent C Bender; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  Cholesterol, lipid rafts, and disease.

Authors:  Kai Simons; Robert Ehehalt
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 4.  The serotonin1A receptor: a representative member of the serotonin receptor family.

Authors:  Thomas J Pucadyil; Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

5.  GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes.

Authors:  Jinjun Shi; Tinglu Yang; Sho Kataoka; Yanjie Zhang; Arnaldo J Diaz; Paul S Cremer
Journal:  J Am Chem Soc       Date:  2007-04-13       Impact factor: 15.419

Review 6.  TLR-mediated immune responses in the urinary tract.

Authors:  Jeongmin Song; Soman N Abraham
Journal:  Curr Opin Microbiol       Date:  2008-02-01       Impact factor: 7.934

7.  Cytolethal distending toxin-induced cell cycle arrest of lymphocytes is dependent upon recognition and binding to cholesterol.

Authors:  Kathleen Boesze-Battaglia; Angela Brown; Lisa Walker; Dave Besack; Ali Zekavat; Steve Wrenn; Claude Krummenacher; Bruce J Shenker
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

8.  Designing therapies against experimental visceral leishmaniasis by modulating the membrane fluidity of antigen-presenting cells.

Authors:  Subha Banerjee; June Ghosh; Subha Sen; Rajan Guha; Ranjan Dhar; Moumita Ghosh; Sanchita Datta; Bikramjit Raychaudhury; Kshudiram Naskar; Arun Kumar Haldar; C S Lal; K Pandey; V N R Das; Pradeep Das; Syamal Roy
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

Review 9.  Membrane organization and function of the serotonin(1A) receptor.

Authors:  Shanti Kalipatnapu; Amitabha Chattopadhyay
Journal:  Cell Mol Neurobiol       Date:  2007-08-21       Impact factor: 5.046

10.  Clostridium perfringens iota toxin: characterization of the cell-associated iota b complex.

Authors:  Bradley G Stiles; Martha L Hale; Jean Christophe Marvaud; Michel R Popoff
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.